Published in AIDS Weekly, August 28th, 2006
"Lipodystrophy (lipo) and metabolic derangements associated with an increased cardiovascular risk are observed frequently in human immunodeficiency virus (HIV)-infected patients who receive antiretroviral treatment (ART).
"The objective of the study was to provide detailed biochemical information about metabolic syndrome in this condition," wrote scientists in the journal Metabolism - Clinical and Experimental.
According to the authors, "One hundred forty-six HIV-infected male and female patients on ART for more than 6 months were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.